Bentsur Ron 的 Form 4 申報
Nuvectis Pharma, Inc.（NVCT），2023/3/16 申報
- 申報編號
- 0001104659-23-033354
- 申報時間
- 2023/3/16
- 交易日
- 2023/3/14-3/15
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 2 筆非衍生性交易。公開市場買進合計 $2.35 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Bentsur RonCIK 0001251213 | 董事、高階主管（董事長、執行長）、持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
Reflects the weighted average purchase price. The range of prices for the shares purchased was $10.71 to $10.99. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Reflects the weighted average purchase price. The range of prices for the shares purchased was $10.605 to $11.10. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
表 I 有 1 筆交易的價格引用這則附註。